It's good that a powerful ZYL shareholder has encouraged the ASX to ask the questions.Helps clear things up for shareholders and btw, ZYL has responded very well.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025